Chapter 3 WPG0003: Destiny Decision Begins!
Li Wenya looked at the silent An Wuyan, a look of helplessness flashed in her eyes, but she continued, "Actually, the group's situation is far worse than you know, but we haven't told you."
"For example, the group's operating conditions have not been very good in the past three years. Sales have dropped year by year, and net profit has dropped even more. If R&D investment is included, the group has actually suffered a net loss since the year before last." Li Wenya Added to the worse situation.
So is the family business that once had an annual profit of less than 50 million yuan already in turmoil?
An Wuyang felt a little enlightened.
"So our family is bankrupt?" An Wuyang looked at his mother.
"It depends on what your father wants." Li Wenya looked at An Huchun.
"Although Wugengtian Pharmaceutical Group is our family business, and your father is the legal person himself, it is also a limited liability company, and its registered capital is only 1 million Xia Guoyuan." Li Wenya added.
An Wuyang immediately understood what Li Wenya meant. If their family separated from Wugengtian Pharmaceutical Group and implemented bankruptcy liquidation of Wugengtian Pharmaceutical Group, then the problems caused by Wugengtian Pharmaceutical Group would not affect their family.
In fact, this is also the choice of most ‘limited liability companies’, after all, it is only limited liability!
An Huchun whispered, "Wifangtian is your grandfather's hard work, and it is also the hard work of our An family. Our An family has invested too much in it, I"
"I think." An Huchun didn't know how to speak.
An Wuyang took the initiative to ask, "Mom, if the group does not choose bankruptcy and liquidation, what will be the consequences?"
"The result is pretty bad." Li Wenya concluded first.
"For the group, first of all, it must lay off a large number of employees, stop production at the new factory, and sell the new factory to obtain cash flow." Li Wenya explained.
Li Wenya added, "In fact, the difficulties the group is facing today are not just because your father invested a lot of money in research and development."
"The most fundamental reason is that the group does not have core technological competitiveness." Li Wenya pointed out the core problem.
"There are also reasons for the failure of the centralized pharmaceutical procurement competition. On the 2nd of this month, the fifth centralized procurement of pharmaceutical companies was officially launched. In this round of centralized procurement of 62 types of drugs, our group bid for [Esiomei for Injection] "Lazole Sodium] is eligible for centralized procurement," Li Wenya explained in detail.
“In the bidding for centralized procurement qualifications for [esomeprazole sodium for injection], we lost to Caimei Pharmaceutical.” Li Wenya sighed.
"Caimei Medicine. Our old rival?" An Wuyang frowned.
Caimei Pharmaceutical is also a pharmaceutical company in Shengqing. It is an old rival of Wugengtian Pharmaceutical Group.
"Yes." Li Wenya added helplessly, "The other party directly quoted 44.3 yuan for 10 bottles of 40mg standard single bottle [esomeprazole sodium for injection], and we quoted 59.8 yuan."< br>
"Are they crazy?" An Wuyang complained.
Because under normal circumstances, 10 bottles of a single 40mg standard [esomeprazole sodium for injection] sells for more than 100 yuan, and in some areas it can even be sold for a high price of 200 yuan.
However, Caimei Pharmaceutical actually lowered the collective purchase quotation to 44.3 yuan, which is simply
Although the essential purpose of the imperial court's organization of centralized pharmaceutical procurement is to obtain lower drug purchase prices, thereby benefiting more ordinary people, for pharmaceutical companies, such ultra-low quotes mean loss of profits.
Some people may think that pharmaceutical companies only make shady money, and their profits should be reduced.
However, the problem is not that simple.
Take Wugentian Pharmaceutical Group and Caimei Pharmaceutical Company as examples. Wugentian Pharmaceutical Group is a research and development pharmaceutical company, while Caimei Pharmaceutical Company is a generic pharmaceutical company.
For Caimei Pharmaceutical Company, they have no R&D investment and only need to copy drugs whose patents have expired. Its overall cost will be quite low, so it has more room for negotiation.
Wugengtian Pharmaceutical Group is different. It invests a lot of money in the research and development of new drugs every year.
Even though Wugengtian Pharmaceutical Group has not produced any research results, it has also invested a lot of research and development funds. When the comprehensive profit of Wugentian Pharmaceutical Group decreases, it will either transform into a generic pharmaceutical company like Caimei Pharmaceutical Company, or it will directly go bankrupt and liquidate, or it will reduce its R&D investment and survive.
Are these results all about bad money chasing good ones?
"Although the results of the fifth centralized medical procurement will not be announced until three days, we have already obtained the results in advance. It should be said that all companies have obtained the results in advance." Li Wenya sighed again.
"This result is the last straw that breaks the camel's back for our group. It completely defeats our group in terms of marginal cost and human resource cost." Li Wenya said with regret.
"In view of the fact that the group has failed in many medical procurements, and your father wants to preserve the group, according to my preliminary estimation, in addition to selling the property rights of the new factory, we will probably lose most of the family assets. "Li Wenya added.
"In addition, your father once promised you that he would buy you a sports car after you take the college entrance examination, but under the current circumstances, he can only break his promise." Li Wenya added.
The family business is about to go bankrupt, so why buy a sports car?
An Huchun answered, "Now we are faced with two choices."
"First, we carry out bankruptcy liquidation of the group. Through this operation, we can retain most of the family property. Although we have lost the group, you will be worry-free for the rest of your life." An Huchun explained.
The first option is obviously more beneficial to An Wuyang.
"Second, it is very difficult for us to save the group, and we may even be heavily in debt in the end." An Huchun deliberately made the problem more serious.
"I have discussed it with your mother, and the choice this time is left to you." An Huchun motioned to An Wuyang to make the final decision.
Check out the 16-9 book bar and see the correct version!
……
'bite! ’
‘The Destiny Decision Begins! ’
————————
‘Plan A: Choose Wugengtian Pharmaceutical Group for bankruptcy liquidation. ’
‘Reward A: The system will assist the host in opening up a new business territory. ’
————————
‘Plan B: Cooperate with An Huchun to save the family business Wugengtian Pharmaceutical Group. ’
‘Reward B: Comprehensive rewards will be obtained based on the specific rescue plan and execution results. ’
……
The Happy Life System suddenly sent out a message in An Wuyang's mind. An Wuyang pretended to think, but in fact he was checking the information presented by the Happy Life System in his mind.
'Happy life system.' An Wuyang sighed secretly.
It was originally thought to be a junk snack-level gadget, but now the family business with an annual income of half a billion has undergone changes, and this happy life system has begun to become important.
It seems like he has to work hard!
Otherwise, how can we turn the tide and help the building before it collapses?
(End of chapter)